DSM Sinochem Pharmaceuticals
DSM Sinochem Pharmaceuticals, a global leader in generic anti-infective molecules, was formed in 2011 as a 50/50 joint venture between DSM and Sinochem.
On 29 June 2018 Bain Capital announced the proposed acquisition of DSM Sinochem Pharmaceuticals. The transaction is expected to be completed in the fourth quarter of 2018, subject to customary regulatory approvals and consultations, and DSM expects to receive approximately €275 million in cash following closing, including repayment of debt and after transaction costs.
In July 2015 DSM formed ChemicaInvest, a new joint venture with CVC Capital Partners. ChemicaInvest is a global leader in the production and supply of caprolactam and the leading European supplier of acrylonitrile and composite resins. DSM owns 35% of ChemicaInvest which has three business units: